Cell and Gene Therapies (CGT)
Biologic based medicines are as important today as synthetically produced medicines. New therapies like cell and gene therapies (CGT) offer huge potential as treatments for a wide range of diseases including cancer, neurological, and genetic diseases. Therefore, it’s essential to reduce manual labor and integrate processes and workflows with industry-specific automation hardware and software.
![Reduce time to market for new therapies for genetic and orphan diseases pharma-cell-gene-therapies-cgt](https://assets.new.siemens.com/siemens/assets/api/uuid:ada7d0a6-4b09-4fb0-b7ba-40d398f11f4c/width:100/quality:low/crop:0,282:0,1797153024911032:0,614:0,8202846975088968/pharma-cell-gene-therapies-cgt.jpg)
Biologic based medicines are as important today as synthetically produced medicines. New therapies like cell and gene therapies (CGT) offer huge potential as treatments for a wide range of diseases including cancer, neurological, and genetic diseases. Therefore, it’s essential to reduce manual labor and integrate processes and workflows with industry-specific automation hardware and software.